Linguissi Laure Stella Ghoma, Gwom Luc Christian, Nkenfou Celine Nguefeu, Bates Matthew, Petersen Eskild, Zumla Alimuddin, Ntoumi Francine
Fondation Congolaise pour la Recherche Médicale, Cité OMS, villa D6, Djoué, Brazzaville, Republic of Congo; Centre de Recherche Biomoleculaire Pietro Annigoni (CERBA), Labiogene, Université de Ouagadougou, Ouaga, Burkina Faso.
Chantal Biya International Reference Centre, Yaoundé, Cameroon; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Int J Infect Dis. 2017 Mar;56:62-67. doi: 10.1016/j.ijid.2016.10.012. Epub 2016 Oct 27.
The Republic of Congo is on the World Health Organization (WHO) list of 'high burden' countries for tuberculosis (TB) and HIV. TB is the leading cause of death among HIV-infected patients in the Republic of Congo. In this viewpoint, the available data on TB and HIV in the Republic of Congo are reviewed, and the gaps and bottlenecks that the National TB Control Program (NTCP) faces are discussed. Furthermore, priority requirements for developing and implementing TB and HIV collaborative service activities are identified. HIV and TB control programs operate as distinct entities with separate case management plans. The implementation of collaborative TB/HIV activities to evaluate and monitor the management of TB/HIV co-infected individuals remains inefficient in most regions, and these activities are sometimes non-existent. This reveals major challenges that require definition in order to improve the delivery of healthcare. The NTCP lacks adequate resources for optimal implementation of control measures of TB and HIV compliance and outcomes. The importance of aligning and integrating TB and HIV treatment services (including follow-up) and adherence support services through coordinated and collaborative efforts between individual TB and HIV programs is discussed. Aligning and integrating TB and HIV treatment services through coordinated and collaborative efforts between individual TB and HIV programs is required. However, the WHO recommendations are generic, and health services in the Republic of Congo need to tailor their TB and HIV programs according to the availability of resources and operational feasibility. This will also open opportunities for synergizing collaborative TB/HIV research and training activities, which should be prioritized by the donors supporting the TB/HIV programs.
刚果共和国是世界卫生组织（WHO）列出的结核病（TB）和艾滋病毒“高负担”国家。结核病是刚果共和国艾滋病毒感染患者的主要死因。基于这一观点，本文回顾了刚果共和国结核病和艾滋病毒的现有数据，并讨论了国家结核病控制规划（NTCP）面临的差距和瓶颈。此外，还确定了开展和实施结核病与艾滋病毒联合服务活动的优先需求。艾滋病毒和结核病控制规划作为不同的实体运作，有着各自独立的病例管理计划。在大多数地区，评估和监测结核病/艾滋病毒合并感染个体管理情况的结核病/艾滋病毒联合活动的实施效率仍然低下，有些地区甚至不存在此类活动。这揭示了一些重大挑战，需要加以明确以改善医疗服务的提供。国家结核病控制规划缺乏足够资源来最佳地实施结核病和艾滋病毒依从性及治疗结果的控制措施。本文讨论了通过结核病和艾滋病毒各项目之间的协调与合作，使结核病和艾滋病毒治疗服务（包括随访）以及依从性支持服务保持一致并整合起来的重要性。需要通过结核病和艾滋病毒各项目之间的协调与合作，使结核病和艾滋病毒治疗服务保持一致并整合起来。然而，世卫组织的建议是一般性的，刚果共和国的卫生服务需要根据资源可用性和操作可行性来调整其结核病和艾滋病毒项目。这也将为结核病/艾滋病毒联合研究和培训活动的协同增效创造机会，支持结核病/艾滋病毒项目的捐助方应将这些活动列为优先事项。
